Long intergenic non-protein coding RNA 2041 (LINC02041)

Long intergenic non-protein coding RNA 2041 (LINC02041) is a human long non-coding RNA gene, classified specifically as a long intergenic non-coding RNA (lincRNA)[1][3]. LINC02041 transcripts are not believed to encode proteins but may regulate gene expression and chromatin structure[5][7]. Clinically, LINC02041 is significantly upregulated in various tumors, especially pancreatic adenocarcinoma, and its high expression correlates with a higher hazard ratio and poorer 5-year survival in such patients, indicating its value as a prognostic biomarker[3]. It is also part of lncRNA-based models for predicting overall survival in head and neck squamous cell carcinoma and shows diagnostic performance in colorectal cancer[6][3]. No direct therapeutic targeting, approved drugs, or well-characterized interacting partners are documented; its primary significance is currently as a biomarker and potential mediator of tumor biology, rather than as a therapeutic target or known receptor, enzyme, or transporter[3][6][5].

Other names

RP11-567G11.1linc02041